Database for tracking neonatal infections
Official title: Neonatal Infection Surveillance Database
Run by St George's, University of London · NCT05742490 · Data updated 2026-11-12
This study is creating a system to track and understand bacterial infections in newborns in the UK to help doctors respond quickly and improve care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Minute to 12 Months |
| Sex | All |
| Enrollment | 12000 (estimated) |
| Sponsor | St George's, University of London Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | December 16, 2013 |
| Main results expected | November 22, 2023 |
| Study ends | November 22, 2028 |
| Registry record updated | February 24, 2023 |
| Trial ID | NCT05742490 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are infants in participating neonatal units who have experienced an episode of infection with a positive culture.
✕Probably not a fit
Patients who do not have a diagnosed episode of neonatal infection will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The NeonIN surveillance database is designed to actively monitor bacterial infections in neonates across a network of neonatal units in the UK. It utilizes standardized definitions and microbiological techniques to ensure accurate data collection and analysis. By capturing real-time data on episodes of invasive neonatal infections, the database facilitates timely interventions and enhances understanding of infection patterns. Clinical, demographic, and microbiological information is gathered through a secure web-based platform, allowing for rapid analysis and reporting.
Why it matters
Potential benefit: If successful, this database could significantly improve the management and treatment of neonatal infections, leading to better outcomes for affected infants.
How similar studies have gone: Other studies utilizing similar surveillance approaches have shown success in improving infection management and outcomes in neonatal care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infants on participating Neonatal Units who have an episode of infection with a positive culture Exclusion Criteria: \-
Where it's running
-
St George's University of London
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Eva Galiza, MD — St George's, University of London
- Study coordinator: Sana Ibrahim, BSc
- Email: sibrahim@sgul.ac.uk
- Phone: +44 (0)208 725 5382
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers linked to congenital CMV using newborn blood spots
Researchers will test protein and RNA markers in dried blood spots from newborns to see if they can identify congenital CMV sequelae early.
-
Using a multi-infusion strategy to reduce infections in premature infants
This study tests if using special devices to give multiple medications can help reduce infections in premature infants.
-
Zinc supplementation for infants with severe infections in Tanzania
This study is testing if giving zinc to young infants in Tanzania who are hospitalized with serious infections can help them recover better and live longer.
-
Measuring oxygen extraction in newborns with and without infections
This study is trying to see if measuring oxygen levels in the blood can show differences between newborns with infections and those without, to help understand their breathing problems better.
-
National survey on bacterial meningitis in children
This study is trying to learn more about bacterial meningitis in children by looking at which bacteria are causing it and how things have changed since the introduction of vaccines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.